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The regulatory events guiding progenitor activation
and differentiation in adult white adipose tissue are
largely unknown. We report that induction of brown
adipogenesis by b3-adrenergic receptor (ADRB3)
activation involves the death of white adipocytes
and their removal by M2-polarized macrophages.
Recruited macrophages express high levels of os-
teopontin (OPN), which attracts a subpopulation of
PDGFRa+ progenitors expressing CD44, a receptor
for OPN. Preadipocyte proliferation is highly targeted
to sites of adipocyte clearance and occurs almost
exclusively in the PDGFRa+ CD44+ subpopulation.
Knockout of OPN prevents formation of crown-like
structures by ADRB3 activation and the recruitment,
proliferation, and differentiation of preadipocytes.
The recruitment and differentiation of PDGFRa+ pro-
genitors are also observed following physical injury,
during matrix-induced neogenesis, and in response
to high-fat feeding. Each of these conditions recruits
macrophages having a unique polarization signature,
which may explain the timing of progenitor activation
and the fate of these cells in vivo.
INTRODUCTION
Substantial evidence indicates that adipose tissue dysfunction
contributes importantly to the adverse outcomes associated
with obesity (Rosen and Spiegelman, 2006). Adipose tissues
can exhibit pronounced metabolic and cellular plasticity, and
modulation of cellular phenotypes within adipose tissue offers
a potential means for therapeutic intervention (Sethi and Vidal-
Puig, 2007). For example, peroxisome proliferator-activated
receptor gamma (PPARg) agonists improve metabolic function
in part by promoting fatty acid sequestration, upregulating adi-
ponectin secretion, and suppressing macrophage inflammation
(Maeda et al., 2001; Odegaard et al., 2007; Tontonoz and Spie-
gelman, 2008). Conversely, b3-adrenergic receptor (ADRB3)
agonists also improve metabolic profiles in rodent models of
type 2 diabetes in part by promoting a catabolic phenotype
in existing white adipocytes (WAs) (Granneman et al., 2003;
Himms-Hagen et al., 2000) and by recruiting mitochondrial
uncoupling protein 1 (UCP1)+ multilocular adipocytes from pro-
genitors (Granneman et al., 2005; Lee et al., 2012).Cell MeUtilizing chemical and genetic tracing techniques, we recently
reported that cells expressing the cell-surface markers platelet-
derived growth factor receptor alpha (PDGFRa), CD34, and Sca1
(PDGFRa+ cells) proliferate and differentiate into multilocular
UCP1+ brown adipocytes (BAs) in response to ADRB3 agonist
treatment (Lee et al., 2012). Lineage tracing demonstrated that
PDGFRa+ cells also give rise to unilocular white adipocytes
(WAs) in gonadal and inguinal WAT following high-fat feeding
(Lee and Granneman, 2012; Lee et al., 2012). These results indi-
cate that PDGFRa+ cells have the potential to become BAs or
WAs, depending on the nature of inductive signals.
WAT PDGFRa+ cells have a unique morphology in which
dendritic processes contact numerous cell types in the micro-
environment (Lee et al., 2012). PDGFRa+ cells with similar
morphology are involved in cellular restoration and repair in other
tissues (Joe et al., 2010; Uezumi et al., 2010; Zawadzka et al.,
2010), and we previously proposed that PDGFRa+ cells might
serve a similar function inWAT. To explore mechanisms involved
in adipocyte progenitor recruitment, we used a model of WAT
remodeling induced by treatment with CL 316,243, a highly
selective ADRB3 agonist. ADRB3 are almost exclusively
expressed inWAs and BAs (Granneman et al., 1991), and activa-
tion of these receptors offers a highly selective means of trig-
gering tissue remodeling. In addition, remodeling proceeds
rapidly along a well-defined time course of proliferation and
differentiation (Lee et al., 2012), which allows for detailed
temporal and spatial analysis of remodeling events.
Tissuemacrophages play a critical role in normal development
and during tissue remodeling and repair (Pollard, 2009). Macro-
phages are now recognized as a crucial cellular component of
adipose tissue involved in physiologic and pathologic remodel-
ing (Chawla et al., 2011; Lumeng and Saltiel, 2011; Sun et al.,
2011), and these diverse effects have been linked to variations
in phenotypic polarization. Classically activated (M1) macro-
phages are recruited to adipose tissue during obese states
and appear to promote insulin resistance by triggering local
and systemic proinflammatory signaling (Lumeng et al., 2007;
Strissel et al., 2007; Weisberg et al., 2003). In contrast, alterna-
tively activated macrophages (M2) enhance insulin sensitivity
by PPARg-dependent mechanisms (Odegaard and Chawla,
2011; Odegaard et al., 2007). Nonetheless, it is largely unknown
whether and how macrophages participate in adipogenesis
during remodeling and repair.
We report that brown adipogenesis induced byADRB3 agonist
treatment is triggered by the recruitment of macrophages to
vulnerable white adipocytes undergoing agonist-mediated cell
death. The recruited macrophages express markers that are
characteristic of alternatively activated macrophages (M2) andtabolism 18, 355–367, September 3, 2013 ª2013 Elsevier Inc. 355
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markers. PDGFRa+ progenitors concentrate at sites of dead
adipocyte clearance, the so-called crown-like structure (CLS),
where they proliferate and differentiate into adipocytes. M2mac-
rophages within CLS express high levels of osteopontin (OPN),
which is chemotactic for PDGFRa+ progenitors in vitro. Knockout
of OPN prevents ADRB3-induced macrophage recruitment and
PDGFRa+ progenitor migration, proliferation, and differentiation.
The interaction of PDGFRa+ progenitors and macrophages
in CLS is also observed during high-fat feeding and following
localized tissue damage, and these structures appear to consti-
tute an adipogenic cell niche for tissue repair and remodeling
in adult WAT.
RESULTS
Depot-Specific Adipogenesis Identifies Crown-like
Structure as an Adipogenic Niche
We previously observed that mitogenic responses of PDGFRa+
progenitors varied greatly among adipose tissue depots during
ADRB3-mediated remodeling, yet the in vitroproliferationanddif-
ferentiation of cells isolated from these depots were remarkably
similar (Lee et al., 2012). To gain further insight into depot-specific
progenitor activation, we characterized proliferating progenitors
in gonadal WAT (gWAT) and inguinal WAT (iWAT) by flow cytom-
etry and immunohistochemistry during the course of ADRB3-
mediated remodeling. 129S1 mice were continuously infused
with CL. On the third day of infusion, mice were injected with
EdU to tag dividing cells, and the proliferation and differentiation
of labeled cells were assessed 2 or 96 hr later, respectively. Flow
cytometric analysis of stromovascular cells (SVCs) obtained from
dissociated gWAT confirmed that majority of proliferating cells
expressed PDGFRa (Figure 1A and Figures S1A–S1C) and that
the proliferation of these cells was markedly higher in gWAT
compared to iWAT (Figure 1A and see Figure S1D online). Immu-
nohistochemical analysis confirmed proliferation of PDGFRa+
cells in gWAT on the third day of CL treatment (Figures 1B and
1C) and the differentiation of these cells into multilocular perili-
pin-1 (PLIN1)+ andUCP1+ adipocytes (Figure 1D). Lineage tracing
using Pdgfra-CreER confirmed the presence of numerous multi-
locular adipocytes that were derived from PDGFRa+ progenitors
(Figure S1E). Quantification of double-label immunofluorescence
demonstrated that CL induced greater proliferation (2 hr post-
EdU) (Figure 1C) and differentiation (96 hr post-EdU) of PDGFRa+
cells ingWATthan in iWAT (Figure1E).Althoughagonist treatment
produced far less proliferation in iWAT, the vast majority of cells
that divided on the third day of CL treatment became PLIN1+
adipocytes that expressedUCP1 (Figure 1E). These data indicate
that CL produces a depot-specific induction of progenitor prolif-
eration; however, once recruited to divide, progenitors from
both depots differentiate into BAs at similarly high frequency.
Detailed histological examination at the time of peak prolifera-
tion (day 3) demonstrated that dividing cells in gWAT were found
near cell clusters that surrounded PLIN1-negative vacancies.
These structures were reminiscent of the so-called crown-like
structures (CLS) that are observed during efferocytosis of adipo-
cytes (Cinti et al., 2005). Triple staining for F4/80, PLIN1, and EdU
confirmed that proliferating cells were near F4/80+macrophages
that surrounded the remains of dead/dying (PLIN1-negative)356 Cell Metabolism 18, 355–367, September 3, 2013 ª2013 Elsevieadipocytes (Figure 2A). Because adipocyte triglycerides are
extracted in the process of paraffin embedding, we confirmed
the presence of lipid cores surrounded by macrophages in cryo-
sections (Figure S2A) and in whole-mount staining (see below).
CLS were rarely found in iWAT (Figure 2B), and the appearance
of these structures in gWAT was closely correlated with CL-
induced proliferation (Figure 2C). As expected, agonist treatment
increased expression of Emr1 (the gene encoding F4/80) and the
number of F4/80+ macrophages in gWAT, but not in iWAT, as
determined by immunohistochemical and flow cytometric ana-
lyses (Figures 2D and 2E and Figures S2B and S2C).
We next characterized the distribution of recruited, prolifer-
ating, and newly differentiated PDGFRa+ progenitors by genetic
tagging and immunohistochemistry. Genetic tracing was per-
formedbycrossingmiceharboringastopcodon-floxed tdTomato
reporter gene (R26-LSL-tdTomato) with mice expressing a
tamoxifen-sensitive Cre recombinase under the control of the
Pdgfra promoter (Pdgfra-CreERT2 mice). Upon treatment with
tamoxifen, tdTomato reporter is expressed in PDGFRa+ progeni-
tors, and the migration and fate of these cells can be traced over
time. Whole-mount imaging of tdTomato+ cells in gWAT after
3 days of CL treatment showed that PDGFRa+ cells were closely
associatedwithmacrophageaggregatesasapart of theCLS (Fig-
ure 3A). The highest density of PDGFRa+ cellswas nearCLS, indi-
cating recruitment to these sites. Flash labeling with EdU demon-
strated that PDGFRa+ cells proliferate within the CLS (Figure 3B
and Figure S3). Indeed, 84% of proliferating PDGFRa+ progeni-
torswerewithin 20mmof activeCLS (Figures 3Cand 3D). This dis-
tribution differed significantly from nonmitotic PDGFRa+ cells (p <
0.01) and identifies the CLS as a zone of progenitor proliferation.
Small newlyborn (<20mmdiameter) tdTomato-taggedadipocytes
were occasionally observed near CLS (Figures 3E and 3F); how-
ever, these adipocyte clusters did not contact active CLS.
Alternatively Activated Macrophages that Express High
Levels of Osteoponin Are Recruited to CLS
Functionally distinct subtypes of macrophages have been
described that range from classically activated proinflammatory
macrophages (M1 macrophages) to alternatively activated anti-
inflammatory macrophages (M2 macrophages) (Gordon and
Taylor, 2005). Expression profiling of gWAT demonstrated that
CL treatment strongly upregulated expression of M2 macro-
phage markers (Arginase 1, Il10, Chitinase3-like 3, Clec10a),
whereas expression levels of M1 markers (Serpine1 [Pai1],
Ccl2, Il6, Tnfa, Itgax) were unaffected (Figure 4A). Triple staining
for MGL1 (M2 marker, encoded by Clec10a), PLIN1, and lipid in
whole-mount gWAT confirmed that M2 macrophages formed
CLS and surrounded lipid droplets devoid of PLIN1 (i.e., the
remnant adipocyte lipid core) (Figure 4C).
Macrophages within the CLS were engorged with neutral lipid,
indicating that these cells play an active role in clearing of the
lipid remains of dead fat cells. Consistent with immunohisto-
chemical analysis, flow cytometry demonstrated that CL treat-
ment induced the appearance of MGL1+ macrophages that
were large (forward scatter area, FSC-A), granular (side scatter
area, SSC-A), and intensely positive for neutral lipid (LipidTox)
(Figures 4D and 4E and Figure S4). As expected, expression of
M2markers, but notM1, andPpargwere enriched in F4/80+ cells
isolated from mice treated with CL (Figures S4D and S4E).r Inc.
Figure 1. ADRB3 Stimulation Induces Proliferation and Differentiation of PDGFRa+ Cells in gWAT
(A) Flow cytometric analysis of depot-specific proliferation of PDGFRa+ cells from gWAT and iWAT of control mice and mice treated with CL for 3 days and
injected with EdU 2 hr before analysis. Lineage-negative cells were gated and analyzed for EdU incorporation and PDGFRa expression. Representative density
plots and quantification of three independent experiments are shown (values are mean ± SEM; ***p < 0.001).
(B–E) Immunohistochemical analysis of proliferation and differentiation of PDGFRa+ cells in paraffin sections of gWAT and iWAT. Proliferating cells were flashed
labeled on the third day of CL treatment, and cellular phenotypes were examined 2 or 96 hr later.
(B) Representative low (left)- and high-magnification (right) images of gWAT paraffin sections stained for EdU and PDGFRa. Most actively dividing cells expressed
PGDFRa (arrows).
(C) The level of proliferation of PDGFRa+ cells was significantly greater in gWAT versus iWAT. Data are mean ± SEM, n = 4 (***p < 0.001).
(D) Ninety-six hours after flash labeling, most cells that divided on day 3 have differentiated into multilocular adipocytes with a central nucleus surrounded by
PLIN+ lipid droplets and expressed UCP1 (arrows).
(E) Although the rate of proliferation was far greater in gWAT versus iWAT (left), the differentiation of EdU+ cells into PLIN1+ (middle) and UCP1+ (right) multilocular
adipocytes did not differ between adipocyte depots. Data aremean ± SEM, n = 4 (***p < 0.001). Sections were counterstained with DAPI (blue). Scale bars, 20 mm.
See also Figure S1.
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Figure 2. Depot-Specific ADRB3-Mediated Proliferation in WAT Correlates with CLS Formation and Macrophage Recruitment
(A) Representative images of paraffin sections of gWAT stained for EdU, F4/80, and PLIN1 on D3 of CL treatment along with amagnified view of the boxed regions
(the bottom row). CLSs are indicated by asterisks in high-magnification fields.
(B) Representative low-magnification images of paraffin sections of gWAT and iWAT stained for F4/80 (left). Quantification of CLS in 2003microscopic fields of
paraffin sections of gWAT and iWAT frommice treated with CL for 3 days (mean ± SEM; n = 6, ***p < 0.001). CLS were defined as circular regions with continuous
rim of F4/80+ cells.
(C) A positive correlation between CLS number and mitotic index. Symbols represent data from individual microscopic fields, with a minimum 5 of 2003 fields of
gWAT paraffin sections from individual mice treated with CL for 3 days (n = 6).
(D) Quantitative PCR analysis of Emr1 expression of gWAT and iWAT on D3 and D7 of CL treatment (mean ± SEM; n = 4; ***p < 0.001).
(E) Quantification of F4/80+ cells in paraffin sections of gWAT and iWAT (mean ± SEM; n = 3; *p < 0.05). Scale bars, 100 mm. See also Figure S2.
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Figure 3. PDGFRa+ Progenitors Are Recruited to CLS, where They Form a Zone of Proliferation
(A) Confocal images of whole-mount gWAT from tamoxifen-induced Pdgfra-CreERT2/tdTomato mice stained for lipid (LipidTox, yellow) and F4/80 (green),
showing close association of PDGFRa+ cells with CLS.
(B) F4/80, PDGFRa, and EdU staining in paraffin sections of gWAT from mice treated with CL for 3 days. Left panel merges images of PDGFRa (red) and EdU
(green) fluorescence. Arrows indicate proliferating PDGFRa+ cells. Middle panel is the merged image of F4/80 (red) with EdU (green), showing close association
between proliferating cells and F480+ macrophages that form CLS.
(C) Frequency distribution of PDGFRa+ cell density near CLS in gWAT from mice treated with CL for 3 days.
(D) Frequency distribution of proliferating and nonproliferating PDGFRa+ cells near CLS. Bins are centered at 10 mm intervals. Insert shows data plotted as
distance versus cumulative frequency.
(E and F) Confocal images of cryosectioned gWAT from tamoxifen-inducedPdgfra-CreERT2/tdTomatomice stained for MGL1 and lipid (E) or PLIN1 (F). Magnified
views of boxed regions show that tdTomato+ multilocular adipocytes near CLS were labeled with lipid (E) or PLIN1 (F). Double positive cells are indicated by
arrows. Scale bars, 20 mm. Nuclei were counterstained with DAPI (blue). See also Figure S3.
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In Vivo Adipogenic NichesMacrophage trafficking depends on the orchestrated release
of chemoattractants, and microarray analysis of gWAT (Granne-
man et al., 2005; and our unpublished data) indicated that
expression of Spp1 (the gene for OPN) was highly upregulated
after 3 days of CL treatment. Detailed time course analysis by
immunoblot and expression profiling confirmed the dramaticCell Meupregulation of mRNA and OPN protein levels (Figures 5A and
5B and Figure S5A). Expression was transient and involved pro-
teolytic processing (Denhardt et al., 2001; Scatena et al., 2007).
Upregulation of OPN coincided with macrophage recruitment
and preceded maximal activation of PDGFRa+ cell proliferation.
High-resolution confocal imaging determined that OPN wastabolism 18, 355–367, September 3, 2013 ª2013 Elsevier Inc. 359
Figure 4. CLSs Induced by ADRB3 Stimula-
tion Contain M2-Polarized Macrophages
(A) Quantitative PCR analysis of anti- and proin-
flammatory gene expression in gWAT from control
(CTL) and CL-treated mice (CLd3). CL treatment
significantly upregulated anti-inflammatory genes
(M2 markers) by 3 days, whereas expression of
proinflammatory markers was not affected by CL
treatment (mean ± SEM; n = 4; *p < 0.05).
(B and C) 3D confocal projection images of whole-
mount gWAT from control mice or mice treated
with CL for 3 days, stained for lipid (nile red), MGL1
(B and C, left panel, green) or PLIN1 (C, right panel,
green). (C) MGL1+ macrophages surround a lipid
droplet devoid of PLIN1, forming CLS.
(D) Dissociated gWAT SVC from CL treated-mice
(CLd3), stained for lipid (LipidTox, red) and F4/80
(green). Arrows indicate double positive cells.
Nuclei were counterstained with DAPI (blue). Scale
bars, 20 mm.
(E) Flow cytometric quantification of large
(FSC-Ahi) MGL+ cells with intense LipidTox stain-
ing (Lipidhi) from SVC of control mice and mice
treated with CL for 3 days (mean ± SEM; n = 4; *p =
0.014). See also Figure S4.
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Gene expression analysis of fractionated dissociated adipose
tissue showed almost exclusive enrichment of Spp1 expression
in F4/80+ cells, indicating that macrophages are a major cellular
source of OPN (Figure S5B).
Several OPN receptors have been reported, including integrin
family members and CD44 (Denhardt et al., 2001). We found that
mRNA levels of CD44 (Figure S5C) were transiently upregulated
in a pattern similar to that of OPN but that expression levels of
several integrins were unchanged or slightly decreased (Fig-
ure S5D). OPN is a well-known chemoattractant for macro-
phages (Wang andDenhardt, 2008), and flowcytometric analysis
confirmed upregulation of CD44 in recruited macrophages (Fig-
ures S5E and S6E). Interestingly, we identified a subpopulation
of PDGFRa+ cells that also expressed CD44. Importantly, the
abundance of this subpopulation expanded dramatically during
remodeling (Figure 5D). FACS analysis of EdU incorporation in
PDGFRa+ cells demonstrated that proliferation was largely
restricted to the subpopulation of PDGFRa+ cells that expressed
CD44 2 and 12 hr after EdU injection (Figures 5E and 5F and Fig-
ure S5G). As expected, CL selectively upregulated expression of
proliferation markers in this subpopulation (Figure 5G). Consis-
tent with a role of OPN in progenitor recruitment, we found that
PDGFRa+ cells migrated to OPN in vitro (Figure 5H). Collectively,
these results strongly suggest that OPNcould be amajor chemo-
kine for establishing CLS and the adipogenic tissue niche.360 Cell Metabolism 18, 355–367, September 3, 2013 ª2013 Elsevier Inc.OPN Is Required for CLS Formation
and ADRB3-Mediated
Adipogenesis from PDGFRa+ Cells
We next used Spp1 knockout mice to
investigate the role of OPN in macro-
phage recruitment and progenitor activa-
tion during CL treatment. Spp1 mutants
were maintained on a C57/Bl6 back-ground, so we confirmed that CL induction of OPN expression
and progenitor proliferation in wild-type C57/Bl6 mice was
similar to that seen in 129S1/SvImJ used above (Figure S6). CL
treatment reduced fat tissue mass and adipocyte size equiv-
alently in wild-type and Spp1-KO mice (Figures 6A and 6B).
Nonetheless, genetic disruption of OPN expression greatly
suppressed recruitment of M2 macrophages and nearly elimi-
nated formation of CLS (Figures 6C and 6D). As expected, CL
treatment failed to increase proliferation of PDGFRa+ cells, as
assessed by FACS (Figures 6E). As a result of defective macro-
phage recruitment during CL treatment, differentiation of adi-
pocytes from proliferating progenitors was greatly reduced in
Spp1-KO mice (Figure 6F).
PDGFRa+ Cells Interact with Macrophages and
Contribute to Adipogenesis in Response to
Environmental, Nutritional, and Physical Stimuli
Adipogenesis can be triggered in adult WAT under numerous
conditions, although the cells that contribute to this plasticity
have not been defined. To test whether PDGFRa+ cell recruit-
ment is a general feature ofWAT tissue restoration, we examined
adipogenesis in response to cold stress and high-fat feeding,
following sterile tissue damage, and during ECM-induced tissue
neogenesis.
Cold-induced upregulation of BA gene expression occurs
mainly within fully differentiated adipocytes of subcutaneous
Figure 5. ADRB3 Treatment Upregulates OPN Expression in CLS-Associated Macrophages and CD44 Expression in a Subpopulation of
PDGFRa-Expressing Cells
(A) Quantitative PCR analysis of Spp1 expression in gWAT from control mice and mice treated with CL at indicated days after treatment (mean ± SEM; n = 4–6,
*p < 0.05).
(B) Immunoblot analysis of gWAT from control mice and mice treated with CL at indicated points. (mean ± SEM; n = 3–5, *p < 0.05, **p < 0.01, ***p < 0.001). CL
increased levels of full-length and cleaved OPN.
(C) Immunohistochemical detection of OPN in F4/80+ cells in paraffin sections of gWAT from mice treated with CL for 3 days. Nuclei were counterstained with
DAPI. Scale bar, 20 mm.
(D) FACS analysis of PDGFRa+CD44+ cells in SVC obtained from gWAT and iWAT of control mice and CL-treated mice (mean ± SEM; n = 3, **p < 0.01).
(E and F) FACS analysis of CD44 expression and EdU incorporation in PDGFRa+ cells in SVC of gWAT from control mice andmice treatedwith CL for 3 days.Mice
were injected with EdU 2 hr before sacrifice. (E) Representative flow profiles of each condition are shown. (F) Quantification of CD44+PDGFRa+ cells and
EdU+CD44+ cells by FACS (mean ± SEM; n = 3; ***p < 0.001).
(G) Quantitative PCR analysis of proliferation maker expression in FACS-isolated cells from gWAT of control mice or mice treated with CL for 3 days (n = 3–4,
mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001).
(H) Effect of OPN on in vitro migration of PDGFRa+ cells from Pdgfra-H2BeGFP mice (mean ± SEM; n = 3; *p < 0.05, **p < 0.01). See also Figure S5.
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Figure 6. OPN Is Required for CLS Formation and ADRB3-Mediated Adipogenesis from PDGFRa+ Cells
(A) Reduction in weight of gWAT from WT and Spp1-KO mice after 3 days of CL treatment (mean ± SEM; n = 4–6; **p < 0.01, ***p < 0.001).
(B) Reduction in size of gWAT adipocytes from WT and Spp1-KO mice after 3 days of CL treatment (mean ± SEM; n = 4–6; **p < 0.01).
(C) Immunohistochemical analysis of CLS in paraffin sections of gWAT fromwild-type (WT) and Spp1-KOmice under control condition (CTL) or after 3 days of CL
treatment (CLd3), stained for F4/80 (green).
(D) Quantitative PCR analysis of macrophagemarker expression in gWAT from control and Spp1KOmice (mean ± SEM; n = 10–11 from two independent cohorts;
*p < 0.05, **p < 0.01, ***p < 0.001).
(E) FACS analysis of EdU incorporation in PDGFRa+ cells from gWAT of WT and Spp1-KO mice treated with CL for 3 days and injected with EdU 2 hr before
analysis (mean ± SEM; n = 3–4; **p < 0.01).
(F) Representative images of paraffin sections of gWAT stained for PLIN1 and EdU and quantification of PLIN1+EdU+ cells (mean ± SEM; n = 4; **p < 0.01). Scale
bars, 100 mm except high-magnification field in (F), where scale bar, 20 mm. See also Figure S6.
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(Barbatelli et al., 2010). Nonetheless, we found that cold stress
(3 days at 4C) induced formation of CLS tissues, recruitment
of M2 macrophages, and proliferation of PDGFRa+ cells in362 Cell Metabolism 18, 355–367, September 3, 2013 ª2013 ElseviegWAT (Figures S7A–S7C). The overall pattern of response was
qualitatively similar to CL treatment, although the magnitude of
macrophage recruitment and proliferation was far less, as would
be expected in this sparsely innervated depot.r Inc.
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25% of total adipocytes during 2 months of high-fat feeding
(Lee et al., 2012), and that this phenomenon is more pronounced
in gWAT versus iWAT. However, it is not known whether adipo-
genesis from PDGFRa+ cells is related to CLS-mediated inflam-
mation or whether these cells are recruited to active CLS. We
found that high-fat feeding induced CLS formation in both
gWAT and iWAT; however, the numbers of CLS and the
expression of proinflammatory markers were greater in gWAT
compared to iWAT (Figure S7D). The frequency of CLS observed
after 8 weeks of HFD (Figure S7E) corresponded to the level of
adipogenesis from tdTomato+ cells, which is about 2-fold
greater in gWAT versus iWAT (Lee and Granneman, 2012).
High-resolution imaging clearly demonstrated that PDGFRa+
progenitors were recruited to CLS (Figure 7A and Figure S7F).
Newly formed tdTomato+ adipocytes were rarely observed close
(100 mm) to active CLS (Figure 7B), suggesting that differentiation
might be suppressed by local inflammatory signals.
As shown above (Figure 1), iWAT is resistant to CL-induced
cell death and de novo adipogenesis; nevertheless, this depot
readily responded to localized damage produced by hypoder-
mic needle microinjections with new fat cell formation from
PDGFRa+ progenitors. This adipogenesis occurred within
10 days of initial damage and was not observed in untreated
pads or in regions of the damaged pad that distal to the microin-
jection sites (Figures 7C and 7D). We also found that PDGFRa+
cells contribute to ectopic fat pad formation within subcutane-
ous Matrigel plugs (Figures 7E and 7F). In this model, macro-
phages and PDGFRa+ cells tagged with tdTomato infiltrated
the plug within 1 week (Figure 7E). This migration began from
the aspect of the plug that contacted the iWAT pad and was
led by tissue macrophages. By 4 weeks, tdTomato+ adipocytes
were found throughout the newly formed fat pad (Figure 7F), and
based on the efficiency of reporter recombination, we estimate
that >40% of adipocytes within the pad were derived from
PDGFRa+ cells.
To characterize phenotype and polarization status of macro-
phages that were recruited during various adipogenic condi-
tions, expression levels of macrophage-associated cytokines
and their receptors were analyzed by quantitative PCR (Fig-
ure 7G). In comparison to CL-mediated remodeling, injured
adipose tissue (3 days after injury) recruited macrophages with
mixed M1/M2 phenotypes, which resembled the characteristics
of early-phase wound macrophages reported in other tissues
(Brancato and Albina, 2011). HFD upregulated expression of
M1, but not M2, markers, unlike ADRB3 remodeling (Figure 7G
and Figure S7D). Gene expression analysis of Matrigel 7 days
after injection confirmed recruitment of macrophages and
PDGFRa+ progenitor cells. Principal component analysis (PCA)
of macrophage gene expression indicated unique patterns of
macrophage polarization under the various adipogenic condi-
tions (Figure 7H). ECM-induced adiponeogenesis was associ-
ated with the most distinct pattern of gene expression that was
mainly explained by component 1. Several genes (e.g., resis-
tin-like alpha, Retlna; interleukin 1 receptor antagonist, Il1rn)
with high loading values to component 1 were identified as
potential markers for macrophage subtypes involved in ECM-
induced adipose tissue neogenesis. The gene expression profile
of macrophages recruited to WAT during CL-mediated remodel-Cell Meing was more similar to injury than HFD. Component 2, which
captured this variation, was enriched with M1 markers that
were indicative of the proinflammatory characteristics of adipose
from HFD-fed mice.
DISCUSSION
Recent work indicates that resident PDGFRa+ cells are
committed progenitors of both BA and WA in adult WAT (Berry
and Rodeheffer, 2013; Lee et al., 2012); however, the mecha-
nisms involved in activation and recruitment of these progenitors
in situ has not been investigated. Under basal conditions, quies-
cent PDGFRa+ cells are evenly distributed throughout WAT
pads, where they extend lengthy dendritic processes that con-
tact numerous cells in the tissue microenvironment. Based on
these morphological characteristics, we hypothesized that
PDGFRa+ cells sense disturbances in the microenvironment
and contribute to tissue repair in adult WAT. In this report, we
investigated the mechanisms and location of progenitor recruit-
ment and proliferation, focusing mainly on WAT remodeling
induced by ADRB3 activation.
ADRB3 agonists induced greater proliferation and differentia-
tion of PDGFRa+ cells in gWAT versus iWAT. However, fate anal-
ysis demonstrated that the main difference between depots
involved rates of progenitor proliferation, but not the ability of
proliferating cells to differentiate into BAs in the presence of
CL. FACS-isolated PDGFRa+ cells from gWAT and iWAT are
also similar with respect to clone formation and adipogenicity
in vitro (Lee et al., 2012). While intrinsic differences likely exist
between PDGFRa+ cells from abdominal and subcutaneous
depots (Wu et al., 2012), these observations strongly suggested
that differences in tissuemicroenvironment related to cell activa-
tion are most important in determining whether cellular plasticity
involves progenitor recruitment, as occurs in gWAT, or meta-
bolic/phenotypic conversion of existing fat cells, as occurs in
iWAT.
Detailed histological analysis demonstrated that ADRB3-
mediated progenitor proliferation was highly correlated with
the appearance CLS. Indeed, individual PDGFRa+ cells accumu-
lated in CLS, where they closely associated with recruited mac-
rophages. Flash labeling with EdU demonstrated that the vast
majority of proliferating PDGFRa+ cells were within 20 microns
of CLS and formed a zone of proliferation at the site of adipo-
cyte efferocytosis. These observations strongly suggested that
PDGFRa+ cells aremobile and sense chemotactic andmitogenic
signals emanating from the CLS microenvironment.
Macrophages are a major cellular component of CLS gener-
ated by HFD (Cinti et al., 2005). The number of F4/80+ macro-
phages in gWAT and expression of macrophage-specific
markers increased after the first day of agonist treatment, before
significant proliferation of PDGFRa+ cells (Lee et al., 2012). CL
treatment increased the number of EdU-labeled macrophages
present in gWAT SVC (by FACS) and in CLS (by immunohisto-
chemistry); however, it is presently unclear whether the increase
in WAT macrophages involves mainly recruitment from circula-
tion or proliferation of resident cells. As expected, agonist treat-
ment did not affect macrophage number or gene expression in
iWAT, where de novo adipogenesis was low. Confocal imaging
of whole-mount gWAT demonstrated that PDGFRa+ progenitorstabolism 18, 355–367, September 3, 2013 ª2013 Elsevier Inc. 363
Figure 7. PDGFRa+ Cells Interact withMacrophages in Adult WAT and Contribute to Adipogenesis during Tissue Repair, Tissue Neogenesis,
and Nutritional Hyperplasia
(A) 3D projection images of CLS in iWAT whole mounts from Pdgfra-CreERT2/tdTomato mice fed HFD for 8 weeks.
(B) tdTomato+ adipocyte clusters that were found in iWAT of HFD-fed mice were not associated with CLS.
(C and D) Needle injury induced the appearance of tdTomato+ adipocyte clusters in iWAT. Shown are cryosections of Pdgfra-CreERT2/tdTomato mice 10 days
after needle injury. (D) A magnified view of the boxed region from (C). Injured sites were marked with DiO (green, left). tdTomato+ multilocular adipocytes (arrows)
contained PLIN1+ lipid droplets.
(E and F) Representative confocal images of Matrigel plugs 7 days or 4 weeks after injection. (E) tdTomato+ progenitors and F4/80+ macrophages were the major
cells infiltrating Matrigel plugs 7 days after injection. (F) Numerous tdTomato+ adipocytes formed 4 weeks after Matrigel injection.
(G) Heatmap showing the unique gene expression profiles of macrophage-associated genes under different adipogenic conditions. Gene expression values are
relative to each control condition. (n = 4–6; bold, p < 0.05).
(H) PCA score plot illustrates distinct gene expression profiles across adipogenic conditions (CLd3, gWAT of mice treated with CL for 3 days; injury, iWAT of mice
3 days after needle injury; HFD, gWAT of mice fed HFD for 8 weeks; neogenesis, Matrigel plug 7 days after injection). Scale bars, 20 mm in (A), (B), and (D). Scale
bars, 100 mm in (C), (E), and (F). See also Figure S7.
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In Vivo Adipogenic Nichescontacted lipid-filled macrophages that surrounded the lipid
remains of dead fat cells. Interestingly, macrophage recruitment
was associated with strong upregulation of markers of alterna-
tive activation (M2), including Arg1, Chi3l3, and Il10, whereas
proinflammatory markers were either unchanged or slightly
reduced. These observations indicate that ADRB3-mediated
adipogenesis involves recruitment of macrophages that mediate
noninflammatory tissue repair (Murray and Wynn, 2011).
Tissue-remodeling macrophages express a complex mixture
of cytokines, matrix remodeling enzymes, and growth factors
that could be involved in progenitor migration, proliferation,
and differentiation (Pollard, 2009; Sica and Mantovani, 2012).
CL upregulated Spp1 expression and OPN protein on the first
day of treatment, before significant progenitor proliferation,
and high levels of OPN were restricted to macrophages associ-
ated within CLS. OPN is a well-known chemotactic factor for
macrophage recruitment through its receptor CD44 (Denhardt
et al., 2001; Ponta et al., 2003; Zhu et al., 2004). Interestingly,
CD44 was also present in a subpopulation of PDGFRa+ cells in
the basal state, and this population nearly tripled in number in
gWAT following CL treatment. In contrast, ADRB3 treatment
had no effect on the number or distribution of CD44+ PDGFRa+
cells in iWAT, where Spp1 was not induced and de novo adipo-
genesis was minimal. We found that OPN was chemotactic for
PDGFRa+ cells in vitro, and the vast majority of proliferating
progenitors in gWAT expressed CD44. Together, these results
identify PDGFRa+CD44+ cells as a subpopulation of progenitors
that is poised to respond to macrophage-derived signals.
We directly tested involvement of OPN and found that the
recruitment of alternatively activated macrophages and the
migration, proliferation, and differentiation of PDGFRa+ cells
were severely attenuated in Spp1 null mice. CLS number was
also greatly reduced, indicating that recruited macrophages
promote the death of vulnerableWA.Spp1 deletion did not affect
the expected reduction in fat mass and adipocyte size, indicating
that OPN did not directly affect ADRB3 signaling. These results
indicate that macrophage and progenitor recruitment require
OPN; however, progenitor proliferation and differentiation
may involve additional signals, such as release of macro-
phage-derived and matrix-bound growth factors (Pollard,
2009), and lipid metabolites. In this regard, we have previously
shown that PPARa ligands derived from lipolysis promote cata-
bolic remodeling of gWAT, and that in the absence of PPARa,
ADRB3 agonists trigger persistent adipose tissue inflammation
(Li et al., 2005).
OPN has previously been implicated in recruitment of macro-
phages to adipose tissue during HFD. This recruitment is
associated with systemic inflammation and insulin resistance
(Chapman et al., 2010; Nomiyama et al., 2007), which are largely
corrected by genetic deletion of Spp1. Although OPN appears to
be a critical chemokine for macrophage recruitment in both CL
and HFD models, polarization to M1 or M2 status within the
CLS clearly differs and is likely influenced by additional factors
such as levels of lipid mediators and endotoxin (Cani et al.,
2007; Kosteli et al., 2010). Because adipose tissue develops
normally in Spp1 null mice, OPN involvement might be restricted
to conditions of adipose tissue restoration and repair.
Pharmacological induction of WAT remodeling by ADRB3
agonists has certain experimental advantages for investigatingCell Mein vivo adipogenesis, including stimulus control and specificity,
and rapid time course. We investigated whether recruitment of
PDGFRa+ progenitors was a general feature of adipogenesis
by genetic tracing under diverse adipogenic conditions. Adipo-
genesis from PDGFRa+ cells was observed in response to phys-
ical and nutritional stimuli, and could be induced by exposure to
extracellular matrix. In each case, progenitor recruitment was
associatedwith, or preceded by,macrophage recruitment. Inter-
estingly, the phenotypic character of recruited macrophages
varied according to activating stimulus.
CL treatment and high-fat feeding both result in fat cell death
and clearance by macrophages (Cinti et al., 2005; Lumeng et al.,
2007; Strissel et al., 2007). Interestingly, gWAT is more suscep-
tible than iWAT to CLS formation induced by diet (Strissel et al.,
2007) or drug treatment, and this susceptibility strongly corre-
lates to greater adipogenesis from PDGFRa+ progenitors (Lee
and Granneman, 2012; Lee et al., 2012). While macrophage-
mediated remodeling appears to underlie adult adipogenensis
under both conditions, there are interesting differences in these
models that may be instructive. One obvious difference is that
CLS induced during CL treatment resolves quickly (by 7 days),
and newly differentiated UCP1+ adipocytes can be found near
active structures. In contrast, CLS formation persists for weeks
or months during HFD, and newly differentiated adipocytes,
while in clusters, are not found near active CLS. We suggest
that the transient versus chronic nature of tissue remodeling
involves differences in immune cell recruitment, and specifically
the fact that high-fat feeding strongly upregulates proinflamma-
tory cytokines that are indicative of M1 polarization, but CL-
induced remodeling does not. Persistent M1 activation is known
to delay tissue restoration following damage (Murray and Wynn,
2011), and the high expression of cytokines like TNF-a is known
to suppress adipogenesis in vitro (Xu et al., 1999). It thus seems
likely that high-fat feeding produces metabolic wounds to WAT
that largely fail to heal.
In summary, recruitment of PDGFRa+ progenitors is a com-
mon feature of de novo adipogenesis induced by pharmacolog-
ical, nutritional, and physical provocation to adult WAT. In the
case of ADRB3-mediated remodeling, this involves a subpopu-
lation of progenitors that express CD44 and are responsive to
macrophage-derived OPN. WAT macrophages assume a range
of phenotypes under various adipogenic conditions and play a
critical role in establishing microenvironments that are condu-
cive to resolution or persistent inflammation.
EXPERIMENTAL PROCEDURES
Mice
129S1/SvImJ (129S1; stock number 002448), C57BL/6J (C57B/6; stock
number 000664), B6.Cg-Gt(ROSA)26Sor_tm9(CAG-tdTomato)Hze/J (Madi-
sen et al., 2010) (R26-LSL-tdTomato; stock number 007909), B6.129S4-
Pdgfra_tm11(EGFP)Sor/J (Pdgfra-H2BeGFP; stock number 007669), and
B6.129S6(Cg)-Spp1tm1Blh/J (Spp1KO; stock number 004936) were pur-
chased from the Jackson Laboratory. Pdgfra-CreERT2 mice (Rivers et al.,
2008) were obtained from William Richardson (University College London).
All animal protocols were approved by the Institutional Animal Care and
Use Committee at Wayne State University.
For continuous ADRB3 stimulation, mice were infused with CL
(0.75 nmol/hr) by osmotic minipumps (ALZET) for up to 7 days. For EdU flash
labeling, mice were injected with EdU (Invitrogen, 2 nmol/mouse, i.p.) at
times indicated in the text. Cre recombination in double transgenic micetabolism 18, 355–367, September 3, 2013 ª2013 Elsevier Inc. 365
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In Vivo Adipogenic Niches(Pdgfra-CreERT2/R26-LSL-tdTomato) was induced by administering tamox-
ifen (Sigma, 300 mg/kg, P.O.) on each of 5 consecutive days. CL treatment
or HFD was started 1 week after the first dose of tamoxifen. For high-fat diet
experiment, 60% fat diet (Research Diet D12492) was introduced at
5–6 weeks of age and continued for 8 weeks. For cold exposure, 129S1
mice (three mice per cage) were kept at 4C for 3 days or maintained at
room temperature as controls. Mice were injected with EdU 2 hr before
sacrifice.
Matrix-induced WAT neogenesis was performed as previously described
(Kawaguchi et al., 1998). Briefly, 250 ml cold Matrigel (BD Biosciences) was
injected subcutaneously into the hind limb regions of tamoxifen-induced
Pdgfra-CreERT2/R26-tdTomato mice. After 1 or 4 weeks, the plugs were
collected and analyzed for gene expression and histology.
Localized cellular injury in WAT was induced by repeated (10 times/pad)
hypodermic needle microinjection of PBS containing Vibrant DiO (Invitrogen,
1:100) to identify sites of damage. Tissues were collected 3 or 10 days after
injection and analyzed for gene expression and histology.
Tissue Processing and Histology
Tissues were processed for histological sections or whole-mount tissue and
subjected to immunohistochemical analysis, as previously described (Lee
et al., 2012). Paraffin sections of iWAT and gWAT (5 mm thick) were analyzed
for CLS number and adipocyte size. CLS was defined as circular region sur-
rounded by F4/80 cells in paraffin sections stained for F4/80 and DAPI. CLS
was counted in at least 5 of 2003 fields from each mouse, and the mean of
CLS number/2003 field obtained from individual mice was used to compare
CLS density between iWAT and gWAT. The values of CLS number/2003 field
and EdU/DAPI (%) from the same field were analyzed to correlate CLS number
and mitotic index. Adipocyte size was measured in paraffin sections stained
for hematoxylin and eosin, and was calculated as themean diameter of at least
100 random adipocytes in 5 of 2003 fields per each sample. The level of EdU
incorporation in PDGFRa+ cells or PLIN1 cells were determined by counting at
least 400 cells per each mouse. All quantification of histologic samples was
carried out as blind analyses.
Nile red (Sigma, 1mg/ml) or LipidTox (Invitrogen, 1:300) was used for lipid
staining. EdU was detected according to the instructions of the manufacturer
(Invitrogen).
WAT Stromovascular Cell Fractionation and Flow Cytometry
For FACS analysis, SV fractions from mouse WAT were isolated, as previ-
ously described (Lee et al., 2012). Lipid staining (LipidTox, 1:1000) was per-
formed on cells following live-cell-surface marker staining and fixation. For
EdU detection, fixed SVCs were processed for Click-it reaction first, followed
by cell-surface marker staining. Anti-CD45-PE/Cy7 and CD11b-PE/Cy7 anti-
bodies (Biolegend, rat, 1:300) were used to exclude hematopoietic lineage.
Flow cytometry was performed at the Microscopy, Imaging, and Cytometry
Resources Core of Wayne State University. Cell sorting and analytic cytom-
etry were using FACS Vantage SE SORP and BD LSR II (BD Biosciences)
flow cytometers, respectively. All compensation was performed using single
color controls in BD FACS DiVa software at the time of acquisition. Repre-
sentative cell density plots of negative and positive controls were provided
to show that fluorescence signals from single color controls do not overlap
with any other color channels (in supplemental information). Raw data
were processed using FlowJo software (Tree Star) or CellQuest (BD
Biosciences). Alternatively, dissociated adipose tissue was fractionated
for gene expression analyses by magnetic sorting with anti-F4/80-FITC/
anti-FITC-microbeads and anti-PDGFRa-PE/anti-PE-microbeads (Miltenyi
Biotech).
Statistical Analysis
Statistical analyses were performed with GraphPad Prism 5. Data are
presented as mean ± SEM. Statistical significance between two groups was
determined by unpaired t test or Mann-Whitney test, as appropriate. Compar-
ison among groups was performed using one-way ANOVA or two-way
ANOVA, with Bonferroni posttests to determine the relevant p values. Statisti-
cal significance in distance analysis was evaluated by nonlinear regression.
PCA was performed with XLStat to detect the common variations between
variables and to visualize clusters of correlated observations.366 Cell Metabolism 18, 355–367, September 3, 2013 ª2013 ElsevieSUPPLEMENTAL INFORMATION
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